Goodwin Procter has announced that Adam Dilluvio has joined the firm as a partner in its life sciences group and health-care practice based in New York. Dilluvio’s expertise extends across multiple facets of the corporate lifecycle for life sciences companies, encompassing mergers and acquisitions, leveraged buyouts, minority investments, early-stage financings, restructurings, carve-outs, joint ventures, and strategic licenses. This move marks a significant addition to Goodwin’s robust life sciences and healthcare legal practice.
Prior to joining Goodwin, Dilluvio served as the general counsel at Gurnet Point Capital, where he leveraged his extensive experience in legal advisory for investment activities. His transition to Goodwin is expected to enhance the firm’s capabilities in providing comprehensive legal services to clients within the life sciences sector. For further details, you can view the announcement from Goodwin Law.
This appointment underscores Goodwin’s commitment to strengthening its advisory capacity in the dynamic life sciences industry, aligning with the firm’s strategic goals to support businesses across varying stages of growth and development. Legal professionals and corporate entities can monitor such shifts in human capital as they often presage significant strategic initiatives within firms. More information on this can be found at Bloomberg Law.